Skip to the page

Data / Form D filings / Allinaire Therapeutics Inc.

Allinaire Therapeutics Inc.: Form D filing

Allinaire Therapeutics Inc., a company in Cleveland, OH, filed a Form D with the SEC in 2026. The latest, on April 14, 2026, reports $700,000 sold of a $700,000 offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
11000 CEDAR AVE #18, Cleveland, OH, 44106
Phone
(484) 367-7303
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2113399

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 14, 2026New notice$700,000$700,0002Jan 30, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Douglas W.P. HayExecutive Officer, Director
Satish JindalDirector
Samantha GintherDirector
Arthur BertelsonDirector

Other companies in Ohio that filed recently

Every Form D from the week of Apr 13, 2026 · All recent filings in Ohio · All recent Other filings

Read from SEC EDGAR. Amount sold is what Allinaire Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.